Clinical Trial Update: Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating vaginal DHEA to improve vaginal health after radiation in women with gynecologic, anal, or rectal cancer; currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Rectal Cancer
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• DHEA (dehydroepiandrosterone)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Anal Carcinoma, Cervical Carcinoma | Phase 2 | Status: RECRUITING